Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complex Pharmacology of Free Fatty Acid Receptors
Graeme Milligan, Bharat Shimpukade, Trond Ulven, et al.
Chemical Reviews (2016) Vol. 117, Iss. 1, pp. 67-110
Open Access | Times Cited: 249

Showing 1-25 of 249 citing articles:

Free Fatty Acid Receptors in Health and Disease
Ikuo Kimura, Atsuhiko Ichimura, Ryuji Ohue‐Kitano, et al.
Physiological Reviews (2019) Vol. 100, Iss. 1, pp. 171-210
Open Access | Times Cited: 711
Short‐chain fatty acids: microbial metabolites that alleviate stress‐induced brain–gut axis alterations
Marcel van de Wouw, Marcus Boehme, Joshua M. Lyte, et al.
The Journal of Physiology (2018) Vol. 596, Iss. 20, pp. 4923-4944
Open Access | Times Cited: 613
Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs)
Weronika Ratajczak, Aleksandra Rył, A Mizerski, et al.
Acta Biochimica Polonica (2019)
Open Access | Times Cited: 416
Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production
Valentin Sencio, Adeline Barthélémy, Luciana P. Tavares, et al.
Cell Reports (2020) Vol. 30, Iss. 9, pp. 2934-2947.e6
Open Access | Times Cited: 270
Pathogenesis of autoimmune disease
David S. Pisetsky
Nature Reviews Nephrology (2023) Vol. 19, Iss. 8, pp. 509-524
Open Access | Times Cited: 268
Metabolism meets immunity: The role of free fatty acid receptors in the immune system
Elisa Alvarez‐Curto, Graeme Milligan
Biochemical Pharmacology (2016) Vol. 114, pp. 3-13
Open Access | Times Cited: 224
Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology
Medha Priyadarshini, Kumar Kotlo, Pradeep K. Dudeja, et al.
Comprehensive physiology (2018), pp. 1091-1115
Open Access | Times Cited: 192
Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases
Wolf‐Hagen Schunck, Anne Konkel, Robert Fischer, et al.
Pharmacology & Therapeutics (2017) Vol. 183, pp. 177-204
Closed Access | Times Cited: 185
Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling
Elisa Alvarez‐Curto, Asuka Inoue, Laura Jenkins, et al.
Journal of Biological Chemistry (2016) Vol. 291, Iss. 53, pp. 27147-27159
Open Access | Times Cited: 168
Short-chain fatty acid, acylation and cardiovascular diseases
Xiaofeng Chen, Xiangqi Chen, Xiaoqiang Tang
Clinical Science (2020) Vol. 134, Iss. 6, pp. 657-676
Closed Access | Times Cited: 149
Metallaphotoredox-enabled aminocarboxylation of alkenes with CO2
Jun‐Ping Yue, Jincheng Xu, Hai‐Tian Luo, et al.
Nature Catalysis (2023) Vol. 6, Iss. 10, pp. 959-968
Closed Access | Times Cited: 53
Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity
Morten Steen Hansen, Kaja Madsen, Maria Price, et al.
Bone Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Palmitic Acid Hydroxystearic Acids Activate GPR40, Which Is Involved in Their Beneficial Effects on Glucose Homeostasis
Ismail Syed, Jennifer Lee, Pedro M. Moraes‐Vieira, et al.
Cell Metabolism (2018) Vol. 27, Iss. 2, pp. 419-427.e4
Open Access | Times Cited: 161
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts
Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 88-127
Open Access | Times Cited: 132
Advances in fatty acids nutrition in dairy cows: from gut to cells and effects on performance
Massimo Bionaz, Einar Vargas‐Bello‐Pérez, Sebastiano Busato
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 125
G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
Darren Riddy, Philippe Delerive, Roger J. Summers, et al.
Pharmacological Reviews (2017) Vol. 70, Iss. 1, pp. 39-67
Open Access | Times Cited: 102
Effect of probiotics on depressive symptoms: A meta-analysis of human studies
Kah Kheng Goh, Yen-Wenn Liu, Po‐Hsiu Kuo, et al.
Psychiatry Research (2019) Vol. 282, pp. 112568-112568
Closed Access | Times Cited: 97
Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators
Manuel Grundmann, Eckhard Bender, Jens Schamberger, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1763-1763
Open Access | Times Cited: 97
Long Chain Fatty Acids as Modulators of Immune Cells Function: Contribution of FFA1 and FFA4 Receptors
María A. Hidalgo, María Daniella Carretta, Rafael A. Burgos
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 95
Non-Acidic Free Fatty Acid Receptor 4 Agonists with Antidiabetic Activity
Carlos M. G. Azevedo, Kenneth R. Watterson, Edward T. Wargent, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 19, pp. 8868-8878
Open Access | Times Cited: 93
FFA4/GPR120: Pharmacology and Therapeutic Opportunities
Graeme Milligan, Elisa Alvarez‐Curto, Brian D. Hudson, et al.
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 9, pp. 809-821
Open Access | Times Cited: 92
Gut microbiota modulation with traditional Chinese medicine: A system biology-driven approach
Shi‐Jun Yue, Wenxiao Wang, Jingao Yu, et al.
Pharmacological Research (2019) Vol. 148, pp. 104453-104453
Closed Access | Times Cited: 82
Influenza Virus Infection Impairs the Gut’s Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids
Valentin Sencio, Alexandre Gallerand, Marina Gomes Machado, et al.
Infection and Immunity (2021) Vol. 89, Iss. 9
Open Access | Times Cited: 66
Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes
Tulika Arora, Valentina Tremaroli
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 64
Short-Chain Fatty Acid and FFAR2 Activation – A New Option for Treating Infections?
Katja Schlatterer, Andreas Peschel, Dorothee Kretschmer
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top